Advertisement

Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections

Dana T. Lounder, Qiong Bin, Cristina de Min and Michael B. Jordan

Article Information

Citation 
vol. 3 no. 1 47-50
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted September 8, 2018
  • Accepted December 6, 2018
  • Published online January 7, 2019.


Contributors 
  • Dana T. Lounder, 1Cancer and Blood Diseases Institute and
  • Qiong Bin, 2Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH;3Department of Pediatrics, Affiliated Hospital of Guilin Medical University, Guangxi, China;
  • Cristina de Min, 4Novimmune SA, Plan-les-Ouates, Geneva, Switzerland; and
  • Michael B. Jordan, 2Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH;5Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output